# Delivery Order #SPE2DP26F6421

Delivery Order for Dexamethasone Supply to Federal Health Agencies

**Buyer:** Defense Logistics Agency

**Award Amount:** $141.89
**Ceiling:** $141.89

**Awarded:** June 08, 2026
**Period of Performance:** Jun 08, 2026 - Jun 23, 2026

**Identifier:** SPE2DP26F6421
**NAICS:** 424210

This award is a delivery order contract issued under a long-standing indefinite delivery vehicle (IDV) pharmaceutical supply agreement with DMS Pharmaceutical Group Inc., a specialized distributor of medical pharmaceuticals. The contract specifically procures dexamethasone sodium, an essential corticosteroid medication widely used in various therapeutic treatments. This delivery order supports ongoing federal health agency needs by providing a critical pharmaceutical product with a short-term, well-defined performance period ensuring timely and reliable fulfillment. It is part of a broader multi-year pharmaceutical supply program that addresses comprehensive medication requirements through a strategic procurement approach. The contract was awarded following competitive government procurement procedures to align with public healthcare supply objectives. The scope of work covers the prompt delivery of dexamethasone sodium within a focused timeframe to meet immediate supply demands. This award expands upon the existing definitive pharmaceutical supply contract awarded to DMS Pharmaceutical Group, which is responsible for supplying a broad portfolio of essential drugs to federal health agencies under a long-term agreement starting in 2025 and anticipated through 2038. The place of performance is in Park Ridge, Illinois, and the contract emphasizes the importance of ensuring uninterrupted access to critical medications supporting public health initiatives.

### Description

8512167775!DEXAMETHASONE SODIU

[View original record](https://www.usaspending.gov/award/CONT_AWD_SPE2DP26F6421_9700_SPE2DX25D9900_9700)